Inato and RealTime eClinical Solutions Team Up to Improve Clinical Trial Efficiency and Data Access

Introduction

In the fast-paced world of clinical trials, efficient site selection and patient recruitment are crucial for the success of medical research. Inato, a leader in trial access technology, has joined forces with RealTime eClinical Solutions to revolutionize how clinical trials are managed. This partnership aims to improve site selection and streamline enrollment processes, giving sponsors better tools to navigate complex trial landscapes.

The Partnership

The alliance between Inato and RealTime eClinical Solutions is set to provide unparalleled insights into site performance and patient access. By integrating RealTime-Devana's extensive TrialAlign site data with Inato’s sophisticated patient access metrics, sponsors and contract research organizations (CROs) will gain a wealth of information at their fingertips. This collaboration brings together over 50 major networks, encompassing more than 2,000 sites through RealTime-Devana and extending to 5,500 sites within Inato’s platform.

Enhanced Site Selection

With the enhanced capabilities provided by this partnership, sponsors will have access to comprehensive site metrics displayed within Inato’s platform. This data-driven approach will allow them to make informed decisions when selecting high-performing sites that are poised to enroll patients effectively. The streamlined user experience promises to simplify the site selection process and ultimately drive better outcomes for clinical trials.

AI-Enabled Innovations

One of the standout features of this partnership is the integration of AI technology into the patient screening process. Inato's AI-enabled pre-screening solution will allow trial sites to quickly identify suitable candidates for their studies, reducing chart review times by an impressive 90%. This enhancement not only alleviates the burden on research sites but also increases their competitiveness, enabling them to showcase their readiness and performance metrics on the Inato and RealTime TrialAlign platforms.

Benefits to Clinical Trials

As Kourosh Davarpanah, Co-founder and CEO of Inato, stated, the aim of this partnership is to democratize clinical research, making it accessible for every patient. The improved access to reliable data on patient availability and trial suitability better positions sites to interact with sponsors, ultimately enhancing the quality and speed of trial enrollments.

Barry Lake, Founder and President of RealTime-Devana, emphasized that combining unbiased site performance data with patient access data represents a significant breakthrough in site selection and trial feasibility. These advancements are expected to empower sites to present their capabilities effectively, fostering stronger collaborations with sponsors based on tangible performance indicators and readiness.

Conclusion

Inato’s and RealTime’s collaborative efforts mark a pivotal development in the clinical trial landscape. By harnessing advanced technology and extensive data analytics, this partnership aims to enhance the overall efficiency of clinical trials, benefiting researchers, sponsors, and most importantly, patients. As the landscape of medical research continues to evolve, initiatives like these will be integral in shaping a more inclusive and productive future.

For more information on Inato, visit Inato's website and learn about RealTime eClinical Solutions at RealTime's website.